FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

المصدر: Nasdaq GlobeNewswire / 28 يوليو 2025 04:00:00   America/Los_Angeles